Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRent ExpenseResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Raymond James Financial (RJF) Research & Development (2016 - 2026)

Raymond James Financial filings provide 17 years of Research & Development readings, the most recent being $194.0 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 185.29% to $194.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $878.0 million, a 89.63% increase, with the full-year FY2025 number at $752.0 million, up 192.61% from a year prior.
  • Research & Development hit $194.0 million in Q4 2025 for Raymond James Financial, down from $543.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $543.0 million in Q3 2025 to a low of $31.0 million in Q2 2021.
  • Median Research & Development over the past 5 years was $72.5 million (2024), compared with a mean of $140.1 million.
  • Biggest five-year swings in Research & Development: skyrocketed 1164.29% in 2021 and later tumbled 82.59% in 2023.
  • Raymond James Financial's Research & Development stood at $112.0 million in 2021, then crashed by 50.0% to $56.0 million in 2022, then increased by 8.93% to $61.0 million in 2023, then increased by 11.48% to $68.0 million in 2024, then skyrocketed by 185.29% to $194.0 million in 2025.
  • The last three reported values for Research & Development were $194.0 million (Q4 2025), $543.0 million (Q3 2025), and $77.0 million (Q2 2025) per Business Quant data.